Category Archives: Gynecology

When Suffering From Endometriosis, The Natural Therapy Fuyan Pill Is A Useful Medicine For Pregnancy Plan Of Female Patients

Los Angeles, California, U.S.A., 2021-Jan-14 — /EPR HEALTHCARE NEWS/ — Reuters recently reported that British lawmakers called for urgent government action to support 1.5 million females with endometriosis — a debilitating condition that leads to absenteeism from school and work and can cause infertility. Female health experts said the lack of funding for research into the crippling illness — which affects one in ten females worldwide — showed how female health issues were often marginalized.

Female health issues should be paid attention to, while endometriosis is very harmful to the body health in females, which can cause persistent dysmenorrhea, menstrual disorders, urinary pain, low back pain, pelvic bleeding and other problems. If things go on like this, endometriosis will affect their learning efficiency, working performance, social life, relationships and mental health. In addition, they may have to face the problem of infertility.

In general, due to the ectopic endometrium attached to the abdominal cavity or ovarian surface, it can cause periodic shedding, congestion, edema, thus leading to the formation of chocolate cysts on the ovarian surface. The abnormal tissues can affect ovulation and then lead to infertility. Furthermore, the ectopic endometrium in the abdominal cavity will cause the viscera to stick together, causing the fallopian tubes to be blocked. In this case, the sperm and the egg cannot be combined into a fertilized egg in the fallopian tube, resulting in female infertility.

If a female friend has endometriosis and suffers from long-term infertility, doctors generally recommend her to receive a surgery to excise the diseased tissues. However, in some cases, due to the serious adhesions of the lesions, doctors are often unable to make a complete elimination, thus leading to a high recurrence rate of endometriosis.

On the flip side, doctors may adopt the therapeutic surgery, which involves the complete removal of both ovaries and the uterus. Actually, it’s relatively cruel to young and childless females, which not only directly deprives them of the reproductive rights, but also potentially triggers postmenopausal syndrome. Surgery can also induce secondary infections, leading to other inflammations such as pelvic inflammatory disease.

Obviously, surgery is a double-edged sword, which surely has some positive effects, but is not the best option, especially for females who want to raise children. A sound body is essential for a successful pregnancy. If you have to suffer from extra pain and risks due to the treatment method, it’s actually not worth trying. As a result, more and more patients with endometriosis are looking for safer solutions, and the natural therapy Fuyan Pill is a useful medicine for them.

The herbal medicine Fuyan Pill is developed by Wuhan Dr.Lee’s TCM Clinic, which has been granted the national patent in China. It can eliminate inflammations, kill various bacteria and viruses, clear away heat, remove blood stasis, relieve pain and so on. It’s made from more than 50 selected herbal ingredients, including radix bupleuri, poria, scutellaria baicalensis, gardenia, Chinese yam, talc, angelica sinensis, peach seed, safflower, licorice, etc.

The Fuyan Pill can effectively relieve the pain and discomfort caused by endometriosis, unblock the fallopian tubes, solve the adhesion issues, and provide a sound physiological environment for fertilization. In terms of traditional Chinese medicine, the cause of endometriosis is qi stagnation and blood stasis, and Fuyan Pill features the ability to promote blood circulation, remove blood stasis, eliminate inflammation and abnormal tissues. It can also regulate the menstruation and hormones, enhance the body immunity, and improve the female self-healing capacity.

As a natural therapy, Fuyan Pill has a strict formula and ratio in terms of the composition. Based on Dr. Lee’s more than 30 years of clinical experience, Fuyan Pill has been proved as an effective and safe oral product, which won’t lead to toxic side effects or unnecessary physiological pain and discomfort. For females who aspire to be a mother, Fuyan Pill can help them overcome endometriosis and get pregnant naturally.

We once cured a patient with endometriosis. Emily, a 28-year-old married female in America, was diagnosed with endometriosis and blocked fallopian tubes in 2017. After several attempts at treatment methods, including laparoscopic surgery and hormone therapy, her problems remained unresolved. Introduced by a friend last year, she contacted us and expressed her strong desire for childbirth through email, so we suggested her taking the Fuyan Pill.

After a month of treatment, Emily said that those painful symptoms had been improved so much that she didn’t hesitate to continue taking the pill for several months. Her illness has improved greatly and she is happy to tell us that she got pregnant two months ago. Now, she is actively preparing for the arrival of her baby.

As a natural plant medicine product, Fuyan Pill has a broad-spectrum bactericidal action with no side effects, which can not only treat endometriosis but also react well on pelvic inflammatory disease, endometritis, salpingitis, chlamydia infection, pelvic abscess, and other related problems. As a result, it can help females solve infertility caused by these gynecological diseases. We hope that females pay more attention to their body health. If you suffer from some problems mentioned above, Fuyan Pill is worth trying.

For more information about Fuyan Pill, please visits: https://global.fuyanpills.com/

About Dr. Lee Xiaoping:
Dr. Lee Xiaoping graduated from Hubei College of Traditional Chinese Medicine, China. She qualified as a herbalist 40 years ago and is a highly experienced medical professional. She specializes in the field of male and female reproductive and urinary system diseases. She has devoted 30 years to her clinic and worked on the formula of Fuyan Pill for years. The medicine has proven to be effective and cured thousands of people who suffered from endometriosis as well as its complications.

Media contact:

Lee Xiaoping
Herbalist
Wuhan Dr.Lee’s TCM Clinic
+86- 027-87105085
wuhandrli@gmail.com
herbalistlee@yahoo.com
wuhandrlee@hotmail.com

Via EPR Network
More Healthcare press releases

LIDBREE™ receives marketing authorization in the United Kingdom

SANTA BARBARA, CALIF., U.S.A. / BUDAPEST / STOCKHOLM, 5-Aug-2020 — /EPR HEALTHCARE NEWS/ — Palette Life Sciences AB (‘Palette’) with Gedeon Richter Plc. (‘Richter’), today announced that as a part of a decentralised regulatory procedure including thirty European Union Economic Area member states, Palette and Richter received national marketing authorization for LIDBREE™ in the United Kingdom (UK). The product is a novel, proprietary thermo gelling intrauterine formulation that can provide significant pain relief during common gynecological procedures.

LIDBREE’s marketing authorization is based on compelling data from clinical trials and investigations of sensory innervation in the reproductive area. In a pivotal clinical trial, LIDBREE treatment was associated with a significant reduction of pain and discomfort in women undergoing gynecological interventions.¹

“Our research group has detected pain nerves superficially throughout the uterus, which enable the use of local pain relief in many gynecological procedures such as insertion of an intrauterine device and sampling biopsies from the cervix and/or from the uterus – procedures that are currently routinely performed today without pain relief. LIDBREE is a novel gel containing the local anesthetic lidocaine which adheres to the mucosal tissue upon application to provide excellent analgesic effect”, says Gunvor Ekman-Ordeberg, MD PhD Professor at Karolinska Institute and founder of the LIDBREE program. “The gratification of observing the culmination of over 40 years of research into clinical practice via a new, simple, and effective treatment is a great privilege to share with all of my colleagues.”

In October 2017, Richter and Palette signed an agreement to commercialise LIDBREE, a novel innovative proprietary pain relief pharmaceutical formulation, in Europe and in certain other markets.

“We are very pleased with the approval of LIDBREE in the UK, it is a great accomplishment from everyone involved.  This is an important milestone and allows us to address a significant unmet medical need in women’s health. We look forward to supporting LIDBREE’s product launch through our partner Gedeon Richter and pursuing additional markets, such as the U.S., in collaboration with future regional partners.” says Helena Jansson, Managing Director at Palette Life Sciences AB.

“We’ve been expecting this regulatory development and we are looking forward to successfully introduce LIDBREE to all of the territories covered by our agreement in order to further improve the quality of life of women experiencing pain during their gynaecological interventions,” stated Tibor Horváth, Commercial Director of Gedeon Richter Plc.

SOURCE: EuropaWire

Europe Home Diagnostics Market: Growth in Pregnancy and Ovulation Predictor Test Kits Sales Encouraging

DUBLIN 2, Ireland, 18-Oct-2018 — /EPR HEALTHCARE NEWS/ — The European home diagnostics industry is realigning to foster integration with the broader customer-centric healthcare services. Growing consumer preference for home-based diagnostics, combined with innovation in online platforms, is creating sustained opportunities in this dynamic landscape. Riding on the coattails of these factors, the US$ 1.4 billion Europe home diagnostics market is likely to grow at 3.4% CAGR during the period 2018-2026.

Consumer Preference for Non-Invasive Glucose Monitoring Devices Still Remains Unmet 

Glucose monitoring kits and devices remain the top-selling product, accounting for over 80% revenue share of the Europe home diagnostics market. The burgeoning demand for home-based glucose monitoring devices and kits can be attributed to growing prevalence of diabetes in Europe, which is increasing across all ages according to the WHO. The Fact.MR study opines that digital devices will remain the preferred choice over cassettes among European consumers.

The broader trends pertaining to non-invasive and painless diagnostics are driving innovation in glucose monitoring device development. According to the Fact.MR study, non-invasive glucose monitoring devices are likely to witness increasing penetration in Europe, albeit at a slow pace. The report also finds that broader innovation in non-invasive devices can drive healthcare consumerism across Europe.

Request a sample of the report

https://www.factmr.com/connectus/sample?flag=S&rep_id=1892

The Fact.MR study remains optimistic on the future growth in Europe’s home diagnostics market, however, challenges prevail. “Self-testing, especially for people with type 1 diabetes, who require daily or frequent testing, remains a painful and inconvenient process. Over the decades, the innovation in glucose monitoring devices hasn’t really addressed the invasive part of the self-testing”, says Mr. Santosh Kumar, Senior Consultant at Fact.MR. “There is an urgent need for non-invasive glucose monitoring testing,” adds Mr. Kumar.

The Fact.MR study finds that home diagnostics manufacturers are aware of the evolving demand. Investment and research into developing minimally or non-invasive home diagnostics devices is gaining ground. “The realization that digital, and non-invasive devices are the future is dawning upon manufacturers. Market leaders, such as Siemens Healthcare and Abbott Technologies are leveraging wearable technologies and IoT to develop innovative products,” says Mr. Kumar.

Growth in Pregnancy and Ovulation Predictor Test Kits Sales Encouraging 

Although glucose monitoring devices and kits will account for the majority of sales, encouraging trends in other self-test kits continue to complement market growth. Pregnancy test kits and ovulation predictor test kits are likely to witness surging demand, as an increasing consumer base feels confident about self-testing. Gains are also encouraging, albeit miniscule, in other home diagnostics products, such as urinary tract infection kits and male infertility test kits.

UK Maintains its Numero Uno Position, Germany and France Remain Lucrative

The Europe home diagnostics market remains concentrated in the UK, Germany, and France. These three markets collectively account for a market share of nearly 60% revenue share of the Europe home diagnostics market. The Fact.MR study opines that these three markets will witness increasing proliferation of next-gen home diagnostics devices.

Request methodology behind the report

https://www.factmr.com/connectus/sample?flag=RM&rep_id=1892

Fact.MR study on the home diagnostics market brings interesting insights to the fore. According to the report, UK remains Europe’s largest market for home diagnostics, with revenues to the tune of US$ 280 million in 2017. The study opines that UK will maintain its numero uno position throughout the course of the forecast period 2017-2026. Germany and France will follow suit, however, sales will grow at a sluggish pace in the former.

The report also finds that home diagnostics devices that use urine and blood for testing will continue to remain pervasive in the Europe home diagnostics market. Samples devices and kits that use semen and breath are expected to witness growth during the course of the forecast period.

Buy the report

https://www.factmr.com/checkout/1892/S

SOURCE: EuropaWire

Will the Catholic Church & the U.S. Courts Embrace Advanced Cell Technologies “Embryo-Safe” Technique Using Embryonic Stem Cells?

Advanced Cell Technology with laboratory facilities in Marlborough Massachusetts has pioneered a solution to the ethical, moral & legal debate raging in regards to protection of a human embryo. ACT has developed the “single-blastomere” technique. Patent Number 7,893,315 a non-destructive alternative for deriving human embryonic stem cell (hESC) lines.

This achievement in Regenerative medicine is a ground breaking feat for both Catholic and U.S. law.
• The 1995 encyclical The Gospel of Life, of which Pope John Paul II wrote: “Human embryos obtained in vitro are human beings and are subjects with rights; their dignity and right to life must be respected from the first moment of their existence. It is immoral to produce human embryos destined to be exploited as disposable ‘biological material'” (1,5 )
• The Dickey Amendment (also known as the Dickey-Wicker Amendment) is the name of an appropriation bill rider attached to a bill passed by United States Congress in 1995, and signed by former President Bill Clinton, which prohibits the Department of Health and Human Services (HHS) from using appropriated funds for the creation of human embryos for research purposes or for research in which human embryos are destroyed.

The single-blastomere technology uses a one-cell biopsy approach similar to pre-implantation genetic diagnosis (PGD), which is widely used in the in vitro fertilization (IVF) process and does not interfere with the embryo’s developmental potential. The stem cells generated using this approach are healthy, completely normal, and differentiate into all the cell types of the human The safety record for one-cell biopsy as part of PGD now has a 15-year track record, and is carried out routinely as part of IVF processes around the world. ACT’s technique of protecting the human embryo from harm can be expounded to the smallest blood transfusion in the world. As does a human being give millions of blood cells in a pint of blood so does ACT’s “single blastomere” process take but “one cell” from a 2 day old embryo. As the blood removed from a human donor “regenerate” the removed pint of blood so does the human embryo “regenerate” the one cell. Both of these procedures leave the human body & two day old embryo healthy. Both procedures are similar in that they both provide life saving material to those whom need them most to due to disease and other aliments of a medical nature.

Via EPR Network
More Healthcare press releases

Side by side comparison of Advanced Cell Technology & Geron Corporation

Regenerative medicine is a highly complicated and vastly misunderstood science. Investor Stem Cell is dedicated to bringing investors and stakeholders together in thoughtful discussion to educate and publicize the incredible advancements unfolding in the regenerative medicine sector. A quantum leap in health care is upon the world. Will you profit from this emerging sector & help bring cures to millions? Find out now what the street thinks at www.investorstemcell.com.

Side by side comparison of Advanced Cell Technology & Geron Corporation:

Geron Corporation (NASDAQ:GERN), Approved by the FDA to use human embryonic stem cell (hESC) treatments to treat spinal cord injuries. The research Goliath is a well-funded machine employing the top minds in the world working on everything from mid-stage oncology trials to promising (hESC) drugs for spinal cord injuries, heart disease & cancer.

Snap shot of Goliath: Geron Corpoartion-(NASDAQ:GERN)-
• Seven oncology Phase 2 trials currently underway, and has several big Pharma joint venture agreements in oncology animal and human trials
• Five hESC areas of investigation underway. GRNOPC1 is the lead candidate. Geron destroys the human embryo through its (hESC) R&D, of which the company uses the blastocyst embryo formation at day five after fertilization from IVF clinics
• Cash, restricted cash, cash equivalents and marketable securities: $221,274.000.00
• Total operating expenses in 2010: $114,730,000.00
• 175 employees; over 100 hold PhD or MD degrees
• Geron Corporation was founded in 1990 and is based in Menlo Park, California
• Trades on the NASDAQ providing liquidity & large institutional investors
• Corporate financial statements:http://www.geron.com/investors/reports/GeronAnnualReport2010.pdf

Advanced Cell Technology not too long ago was the predominant leader in the field of regenerative medicine. It fell from that distinction in part due to executive management hubris and ultimately the credit crisis in mid-2008. ACT was able to resurrect itself from near bankruptcy in June 2008 and now has the distinction of holding two out of the three FDA approved (hESC) trials. ACT is led by a competent executive management team and employs several of the most predominant regenerative researcher(s) in the world.

Snap shot of David: Advanced Cell Technology-(OTC:ACTC)-
• Retinal Pigment Epithelial Cell Program is their lead program-(HESC) trials for both SMD/AMD are expected to start in week(s) Jules Stein Eye Institute at the University of California, Los Angeles (UCLA ) will conduct the 2 (hESC) trials for Stargardt’s Macular Dystrophy (SMD) and Dry Age-Related Macular Degeneration (AMD)
• Filed a European Clinical Trial Application for Phase 1/2 study using (hESC) to treat macular degeneration
• Issued a broad patent for hESC-derived RPE cells in China
• Seeking funding & joint venture partner for Myoblast program for the treatment of cardiovascular disease Phase 2 approved by the FDA
• Joint ventured with Korean medical giant CHA to form “Stem Cell & Regenerative Medicine International” (SCRMI). This partnership expected to file an investigational new drug application (IND) with the FDA in Q-4 of this year. CHA biotech is waiting for final approval from the Korea Food and Drug Administration for (hESC) trial for AMD
• Issued patent on its “single-blastomere” technique. Patent Number 7,893,315 broadly covers ACT’s proprietary single-blastomere technology that provides a non-destructive alternative for deriving hESC lines. This “Embryo-Safe” one-cell biopsy approach similar to pre-implantation genetic diagnosis (PGD), which is widely used in the in vitro fertilization (IVF) process and does not interfere with the embryo’s developmental potential
• 22 full-time employees, six hold PhD or MD degrees-Formed in 1994, HQ in Menlo Park, California with laboratory facilities in Marlborough, MA
• Total operating expenses in 2010: $22,044,701
• Cash, restricted cash, cash equivalents and marketable securities: $34,889,409
• Trades on the OTC:BB ACTC is a Sarbanes–Oxley Act SEC reporter
• Corporate financial statements: http://www.sec.gov/Archives/edgar/data/11...

Via EPR Network
More Healthcare press releases

New Website Dedicated To Stem Cell Investors

Investor Stem Cell (http://www.investorstemcell.com) is dedicated to bringing investors and stakeholders together in thoughtful discussion to educate and publicize the incredible medical advancements taking place in the regenerative medicine sector. Scientists are using stem cells both (hESC) and (iPSC) in hopes of easing the suffering of hundreds of millions of people world wide.

Our society is on the verge of a quantum leap moment in time thanks to regenerative medicine.

Regenerative medicine and Stem Cell research:

Utter those words at your next dinner party or casual gathering of friends and family. You will receive a concoction of half-truth’s and out right fallacy responses. Stem Cell research conjures images of futuristic Star–Trek like preservation chambers, human looking ears protruding oddly from the backs of mice, or worse yet an image of a late term fetus. Nothing could be farther from the truth when entering the reality of Regenerative medicine.

Never before has this area of research been more exciting and promising than right now. There is a medical revolution brewing, and like any revolution, there are those who want to suppress this uprising for continued personal and ideological gains. If we were to take all the major advances in the past 500 years of human medical history and multiply its effect by 10 fold it still would not compare to the paradigm shift in health care delivery that the world may witness in this decade using stem cells. Imagine that an $800,000 heart transplant is no longer needed and that instead the same money spent on one patient can now be stretched out to treat 20 patients who are needing a heart transplant. Is this what Regenerative medicine has in the offing? Only time will tell. Our healthcare system could very well be on the verge of a quantum leap moment thanks to regenerative medicine.

The Food and Drug Administration (FDA) authorized 3 trials using human embryonic stem cells (hESC) in late 2010. Validation of hESC research efforts and the culmination of billions spent on research are coming to fruition. FDA validation for the treatments of spinal cord injury and age related macular degeneration is expected in 2011. It may be the shot heard around the world event sometime in late Q-4 2011 for the Regenerative medicine sector.

Via EPR Network
More Healthcare press releases

Failure to Investigate Cosmetic Surgeon Can Cost You Your Life

A recent death illustrates the importance of investigating your cosmetic surgeon, says Dr. Mark Scheinberg from the Center for Cosmetic Laser Gynecology. Lidvian Zelaya, 35, underwent a procedure for abdominal liposuction and buttocks injections at the Strax Rejuvenation Clinic in south Florida.

She was rushed to the hospital, but died only a few hours after the start of the procedure. Investigations of public records by ABC News reveal that Dr. Roger L. Gordon, Zelaya’s plastic surgeon at Strax, has had 20 lawsuits filed against him since 2004. He was placed on probation by the Maryland Board of Physicians for undisclosed reasons and he had his staff privileges terminated by the Florida Medical Center. The Sun Sentinal revealed that Gordon was disciplined by the state in connection with two deaths in 2004.

“If you’re choosing a plastic surgeon, you want to do your homework,” says Scheinberg. “You’re entrusting them with your body – and your life. You need a doctor you can have confidence in.”

Scheinberg has been board certified in obstetrics and gynecology since 1981 and has performed over 10,000 surgical procedures. Scheinberg has received 100s of hours of training with Professor Adam Ostrzenski, M.D. Ph.D., a pioneer in safe, effectivevaginal reconstruction and cosmetic vaginal surgery.

Zalaya’s cause of death is under investigation, but she was declared healthy enough for surgery by doctors at the Strax Clinic. “I think it’s an inherent conflict of interest if you are getting screened by the surgeon who wants to do the procedure,” said Spencer Aronfeld, a malpractice attorney retained by Zalaya’s husband, Osvaldo Vargas.

Vargas has been publicizing the case as a way of warning others to investigate their cosmetic surgeons. In particular, he is urging patients to get a second pre-operative examination by an independent doctor. He said that Zelaya chose the Strax Clinic because she got a good deal on the procedure.

“You don’t want to rush into this kind of decision or select the doctor who offers you the lowest cost,” notes Scheinberg. “You want someone who has a long record of success with the procedure you are getting. Complaints and disciplinary actions against doctors are part of the public record. Patients can and should look this information up.”

Via EPR Network
More Healthcare press releases

Florida Gynecologist Rebuts Misconceptions About Cosmetic Procedures

Cosmetic gynecology is a burgeoning field with a growing number of practitioners and patients all over the U.S. However, some doctors expressed concern about the field in a recent issue of OB.Gyn News. Many worried that such procedures aren’t medically indicated, while others were concerned about negatively affecting a woman’s self-image by suggesting that her private parts might be unattractive.

However, Dr. Mark Scheinberg, a South Florida cosmetic gynecologist from the Center for Cosmetic Laser Gynecology, knows these criticisms are unfounded. “I have seen hundreds of patients in my practice, “says Dr. Scheinberg. “Many of them have functional concerns, such as pain, difficulty with urine retention, or diminished sexual satisfaction. Aging, childbirth, and other causes can result in some distressing changes in the vulva area. After surgery, they are very happy to have these functions return to normal.”

Other critics have voiced concern that gynecologists’ straying into purely cosmetic treatments is a inappropriate. However, as Dr. Scheinberg points out, “These procedures are no different than breast enhancement or tummy tucks which are performed for cosmetic reasons. Enhancing your appearance is a valid choice for women. It can improve their self-image and quality of life.”

Ultimately, Dr. Scheinberg notes, it’s an issue of giving women choices. “I believe that women should have cosmetic gynecology options,” he says. “It’s not up to me to tell a woman whether she should or shouldn’t be happy with the appearance of the vulvar area. It’s the patient’s choice.”

Learn More
To learn more about the Center for Cosmetic Laser Gynecology and Dr. Mark Scheinberg, visit their Web site at http://cosmeticlasergynecology.com/.

Via EPR Network
More Healthcare press releases

Florida Center for Cosmetic Laser Gynecology Supports Safewalk for Women

Florida cosmetic gynecologist Dr. Mark Scheinberg, a member of the Ultimate Makeovers Team, will participate in the Safewalk Run 5K on October 30th. The 12th annual Safewalk benefits Women in Distress, a non-profit group that provides safe shelter and critical services to families affected by domestic violence.

The event is timed and awards are given to top finishers as well as incentives for top fundraisers. All walkers and runners are asked to raise $200; the walk’s goal is to raise $100,000. The event will be attended by the Miami Dolphin Cheerleaders and organizers expect more than 1,200 people to participate.

Dr. Scheinberg is running in the race and he has also helped to sponsor the event. “At the Ultimate Makeover Team we want to use our resources to help less fortunate individuals and the community as a whole,” said Dr. Scheinberg, a Florida cosmetic gynecology provider.”Sponsoring the Safewalk helps to fulfill both goals.”

Dr. Scheinberg is part of the Ultimate Makeover Program, in which Florida’s best doctors and health practitioners go beyond changing people’s looks to transforming their lives. The Ultimate Team will help the less fortunate through community activism and fundraising corporate partnerships as well as through cosmetic procedures.

Each year the Ultimate Makeover Team will perform a makeover for a deserving member or members of the community at no cost to the participant. The makeover may include cosmetic dentistry, plastic surgery, laser eye surgery, and personal training. Makeover recipients will be chosen from local charities and the community. The Ultimate Team also helps through community activism and corporate partnerships to raise money for charity. This year’s charity is Women in Distress.

Learn More
To learn more about the Center for Cosmetic Laser Gynecology and Dr. Mark Scheinberg, visit their Web site at http://www.cosmeticlasergyn.com/ or phone at 888-573-7496.

Via EPR Network
More Healthcare press releases

Florida Surgeon Describes the Three Most Dangerous Trends in Cosmetic Gynecology

“The vagina is a very complex organ, with complex nerves and muscles,” observes Dr. Mark Scheinberg, a Florida cosmetic gynecologist. “Cosmetic gynecology is a fast growing profession, so, patients need to protect themselves by doing their research about which procedure they need and which practitioner they select.”

There are three dangerous trends in cosmetic gynecology today:

• One Size Fits All

– There are surgeons who perform a florida labiaplasty or vaginal rejuvenation only one way. But, removing too much skin could result in an unnatural appearance, which many patients dislike.
– Every patient’s body is different and each patient desires different results.

• High Volume/Low Cost

– Many surgeons advertise a wide variety of procedures, but this can mean the doctor doesn’t take the time to produce good results.
– A low cost may mean that the doctor is skipping some important steps.
– Be careful when it comes to your private areas.

• One-stop shop

– Some plastic surgeons will offer vaginal rejuvenation and labiaplasty alongside face lifts, breast enhancement, Botox, and other procedures.
– But, these generalists often don’t have much training in such specialized procedures.

When choosing a cosmetic gynecologist, look for the following:

• Experience: How many surgical, gynecological, and cosmetic gynecological procedures has the doctor performed? How long have they been practicing and what is their reputation?

• Advanced training: Look for specific vaginal rejuvenation training – especially advanced training with leaders in the field.

• Multiple methods: Look for a specialist who will design a procedure specifically for you, using a variety of methods and techniques.

• Photos: Check the Web site’s picture gallery and evaluate the quality of the doctor’s work.

•Testimonials: Find out what the doctor’s patients and colleagues are saying.

Learn More
To learn more about the Center for Cosmetic Laser Gynecology and Dr. Mark Scheinberg, visit their Web site at http://cosmeticlasergynecology.com/ or phone at 888-573-7496.

Via EPR Network
More Healthcare press releases

Texting Teen Moms Proves To Be A Convenient Source For Support Bloomington-Based Teen Parenting Group Sees Benefits Of Texting New Teen Moms

Nearly half (47%) of US teens say they can text with their eyes closed. That’s how vital texting has become in their lives.

Texting Teen Moms Proves To Be A Convenient Source For Support Bloomington-Based Teen Parenting Group Sees Benefits Of Texting New Teen Moms

This trend sparked the new text4baby campaign, a free health education program from the National Healthy Mothers, Healthy Babies Coalition that sends pregnancy tips directly to expectant mothers’ cell phones. The new service will send weekly text messages, timed to the mother’s due date or their baby’s birth date.

The messages, written by government and nonprofit health experts, deal with nutrition, immunization and birth defect prevention, among other topics. To sign up, mothers-to-be can just text “BABY” to 511411.

While the national text4baby campaign is new, Bloomington Hospital has already seen the benefits of texting to communicate with new moms. Bloomington Hospital’s Gina Forrest began integrating texting into her Teen Parenting Group in 2008. Forrest sends tips and reminders directly to her teen mom’s cell phones through text messages.

“I communicate with the mothers through texting because that is the easiest and fastest way to do so. Texting has helped me build a relationship with them. They know that they can text me and I will answer,” says Forrest

For Natalie Wineinger, one of the teen moms in Forrest’s group, having texting as a communication option has been really beneficial.

“As a teen mom, I don’t really have time to pick up the phone. Texting is much more convenient for me,” says Wineinger.

Monroe Smart Start Birth to Five Coalition, a local group dedicated to coordinating existing resources to help children in their earliest years, also sees benefits in using texting to communicate with expectant and new moms. Lois Hutter-Pishgahi, director of Monroe Smart Start, is happy to see this new communication method being used nationally and on a local level because of its effectiveness in sharing information about pregnancy and early parenting with young parents.“We believe it makes sense to utilize existing services rather reinventing them. We realized that this is a very effective way of sharing information about pregnancy and early parenting,” says Hutter-Pishgahi.

Because four out of every five teens have a mobile device, Forrest and Hutter-Pishgahi know texting is an effective means of reaching teens like the ones in the Teen Parenting Group.

Forrest texts the mothers to send them reminders about upcoming appointments or meetings. This keeps them updated and less likely to miss appointments. Members of the Teen Parenting Group agree that texting is a convenient way for them to receive information.

“If I don’t know the date for my next appointment, I just text Gina and she can look it up for me. It’s as simple as that,” says Wineinger.

Text messaging represents an enormous yet unused channel for delivering vital health information to those who need it most. Over five billions text messages are sent daily, with texting use higher among women of childbearing age.

Via EPR Network
More Healthcare press releases

South Florida OB/GYN launches The Center for Cosmetic Laser Gynecology

Dr. Mark Scheinberg, M.D., is announcing the recent launch of The Center for Cosmetic Laser Gynecology.

The Center is devoted to empowering women and providing them with knowledge, choice, and alternatives through cosmetic gynecology. “As an OB/GYN, I’ve encountered many patients over the years that complained about the appearance or changes in the sensation and the function of their vagina and surrounding areas,” said Dr. Scheinberg.

Dr. Scheinberg has performed over 6,000 deliveries and over 10,000 gynecological surgical procedures. He has trained under and received certification in cosmetic vaginal surgery from the famed Dr. Matlock of “Dr. 90210,” and recognition has been given to him by the Laser Vaginal Rejuvenation Institute of America (LVRIA). He received advanced training in Cosmetic Vaginal Reconstruction and Transformation by the internationally renowned Professor Adam Ostrzenski, M.D., PH.D.

For those patients with vaginal relaxation and urinary incontinence, Dr. Scheinberg can tighten the vaginal muscles and enhance the strength and control of the vagina throughLaser Vaginal Rejuvenation (LVR) and cosmetic vaginal reconstruction. These can reverse the effects of aging and childbirth and return normal.

Many women are unhappy with the look for their genitalia. Designer Laser Vaginoplasty(DLV) can repair, enhance, and beautify the genitalia. The most common DLV procedures are the Labioplasty/Labiaplasty (minora and majora), Hymenoplasty, Hoodoplasty, reduction of prepuce (excess skin over and lateral of the clitoris).

“I found that traditional gynecology did not give patients the aesthetics and consistent results they were looking for. Patients come into my office with a picture of Playboy and say they want to look like that. We can do that!” said Dr. Scheinberg.

In addition, The Center for Cosmetic Laser Gynecology is now offering Vaser Liposuctionand Brazilian Butt Lifts.

To learn more about Dr. Scheinberg and The Center for Cosmetic Laser Gynecology, visit his website at http://www.cosmeticlasergyn.com

mark-scheinbergAbout Dr. Mark Scheinberg

Dr. Mark N. Scheinberg, M.D., is a Board Certified Gynecologist who can completely resculpt, tighten and rejuvenate the vagina. He was trained by the well known Dr. Matlock of Dr. 90210.

Dr. Mark N. Scheinberg also received advanced training in Cosmetic Vaginal Reconstruction and Transformation by the internationally renowned Professor Dr. Adam Ostrzenski, M.D., PH.D. He is recognized by the Laser Vaginal Rejuvenation Institute (LVRI) and is a member of the International Society of Cosmeto-Gynecologists.

Via EPR Network
More
Healthcare press releases